These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 502784)

  • 1. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 3. Removal of internally deposited transuranium elements by Zn-DTPA.
    Seidel A; Volf V
    Health Phys; 1972 Jun; 22(6):779-83. PubMed ID: 5084010
    [No Abstract]   [Full Text] [Related]  

  • 4. Plutonium: biomedical research.
    Bair WJ; Thompson RC
    Science; 1974 Feb; 183(4126):715-22. PubMed ID: 4595239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological action of 239Pu during intake by inhalation and complexon therapy with Zn or Ca DTPA under experimental conditions].
    Siniakov EG; Nifatov AP; Liubchanskiĭ ER; Bazhin AG
    Med Radiol (Mosk); 1988 May; 33(5):58-61. PubMed ID: 3374306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior and biological action of large amounts of 239Pu following intramuscular administration in rats undergoing long-term therapy with Zn- and Ca-DTPA].
    Siniakov EG; Bazhin AG; Liubchanskiĭ ER; Nifatov AP
    Radiobiologiia; 1987; 27(1):129-30. PubMed ID: 3469686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of standard Licam (C) in plutonium radiocontamination].
    Gerasimo P; Duserre C; Ducousso R; Metivier H
    Ann Pharm Fr; 1987; 45(3):189-94. PubMed ID: 3434970
    [No Abstract]   [Full Text] [Related]  

  • 10. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of ascorbate ions in DTPA treatment after contamination by mixed plutonium dioxide-sodium burning products.
    Métvier H; Masse R; Nolibé D; Nénot JC; Lafuma J
    Health Phys; 1977 May; 32(5):450-2. PubMed ID: 881345
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined effect of DTPA and citrate on an intramuscular 239Pu deposit in rats.
    Volf V
    Health Phys; 1974 Jul; 27(1):152-3. PubMed ID: 4430623
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in the beagle studies at Colorado State University.
    Watters RL; Lebel JL
    Health Phys; 1972 Jun; 22(6):811-4. PubMed ID: 5084015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Behavior and biological effect of 239Pu on entry into a skin abrasion].
    Bazhin AG; Liubchanskiĭ ER; Nifatov AN; Siniakov EG
    Med Radiol (Mosk); 1983 Feb; 28(2):46-51. PubMed ID: 6835046
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward an optimal DTPA therapy for decorporation of actinides: time-dose relationships for plutonium in the dog. I.
    Guilmette RA; Moretti ES; Lindenbaum A
    Radiat Res; 1979 Jun; 78(3):415-28. PubMed ID: 221958
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of phagocytosis and the effect of different DTPA salts on the mechanism of lung self-purification of 239Pu].
    Levdik TI; Osobets SV
    Med Radiol (Mosk); 1980 Oct; 25(10):44-8. PubMed ID: 7421452
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhalation carcinogenesis of high-fired 239PuO2 in rats.
    Sanders CL; Dagle GE; Cannon WC; Craig DK; Powers GJ; Meier DM
    Radiat Res; 1976 Nov; 68(2):349-60. PubMed ID: 988604
    [No Abstract]   [Full Text] [Related]  

  • 18. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of inhaled 239PuF4 in beagles. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.11. PubMed ID: 5306301
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of oral ZnDTPA on late effects of injected plutonium in rat.
    Volf V; Luz A; Schäffer E; Müller WA; Rencová J
    Int J Radiat Biol; 1999 Aug; 75(8):929-41. PubMed ID: 10465359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.